L&L, Indus, S&R, W&C, Freshfields help Carlyle divest $100m in Metropolis Healthcare via BSE block trade

CA Lotus Investments, an investment arm of Carlyle group, sold 65.51 lakh shares of Metropolis Healthcare through a bulk deal on the BSE. The offer size is 13.06 per cent of the outstanding share capital of Metropolis. Currently, CA Lotus holds 71.79 lakh shares or 14.31 per cent stake in the company.

— Hindu Business Line

Goldman Sachs (India) Securities Private Limited was one of the brokers to the block trade.

L&L Partners advised the sellers, the Carlyle Group‘s CA Lotus Investments, led by a team including partnersBikash Jhawar and Jitesh Shahani assisted by managing associatesAvinash Subramanian and Murtaza Zoomkawala.

White & Case advised the Carlyle Group on non-Indian legal aspects.

IndusLaw advised Goldman Sachs (India) Securities Private Limited led by a team of partnerManan Lahoty, partnerManshoor Nazki and associateMansi Jhaveri.

Freshfields Bruckhaus Deringer partnersArun Balasubramanian and Robert Zehbe advised Goldman Sachs on non-Indian laws.

Update 16 April 2020: S&R Associates advised Citibank, which acted as broker to Carlyle, led by a team including partnerSudip Mahapatra and associateAbhiroop Dutta.

2020-04-15

Deal value: $100m

This deal report is based on a firm’s press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

Click here if you are working with a law firm that has not been credited for this deal, and we will update the report promptly.

Click to show comments
at your own risk
(alt+c)

By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click ‘Report to LI’ below the comment and we will review it as soon as practicable.